Systematic identification of pharmacogenomics information from clinical trials

[1]  Xiaoying Wu,et al.  EliXR: an approach to eligibility criteria extraction and representation , 2011, J. Am. Medical Informatics Assoc..

[2]  Mor Peleg,et al.  A practical method for transforming free-text eligibility criteria into computable criteria , 2011, J. Biomed. Informatics.

[3]  Russ B. Altman,et al.  Author ' s personal copy Using text to build semantic networks for pharmacogenomics , 2010 .

[4]  Chunhua Weng,et al.  Semi-Automatically Inducing Semantic Classes of Clinical Research Eligibility Criteria Using UMLS and Hierarchical Clustering. , 2010, AMIA ... Annual Symposium proceedings. AMIA Symposium.

[5]  Yael Garten,et al.  Recent progress in automatically extracting information from the pharmacogenomic literature. , 2010, Pharmacogenomics.

[6]  U. Hahn,et al.  MINING THE PHARMACOGENOMICS LITERATURE – Workshop Introduction , 2010 .

[7]  Jacob de Vlieg,et al.  Literature Mining for the Discovery of Hidden Connections between Drugs, Genes and Diseases , 2010, PLoS Comput. Biol..

[8]  Russ B. Altman,et al.  Pharmacogenomics and bioinformatics: PharmGKB. , 2010, Pharmacogenomics.

[9]  Yu-Li Liu,et al.  Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response. , 2010, Pharmacogenomics.

[10]  Chunhua Weng,et al.  Corpus-based Approach to Creating a Semantic Lexicon for Clinical Research Eligibility Criteria from UMLS , 2010, Summit on translational bioinformatics.

[11]  Lawrence Hunter,et al.  Extraction of Genotype-Phenotype-Drug Relationships from Text: From Entity Recognition to Bioinformatics Application , 2010, Pacific Symposium on Biocomputing.

[12]  C. Mehta,et al.  The future of drug development: advancing clinical trial design , 2009, Nature Reviews Drug Discovery.

[13]  Martin Theobald,et al.  Extraction of Conditional Probabilities of the Relationships Between Drugs, Diseases, and Genes from PubMed Guided by Relationships in PharmGKB , 2009, Summit on translational bioinformatics.

[14]  Russ B. Altman,et al.  Pharmspresso: a text mining tool for extraction of pharmacogenomic concepts and relationships from full text , 2009, BMC Bioinformatics.

[15]  Tony Tse,et al.  Moving Toward Transparency of Clinical Trials , 2008, Science.

[16]  Thomas C. Rindflesch,et al.  Leveraging Semantic Knowledge in IRB Databases to Improve Translation Science , 2007, AMIA.

[17]  J. Kramer,et al.  The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates , 2007, Nature Reviews Drug Discovery.

[18]  K. Bretonnel Cohen,et al.  MutationFinder: a high-performance system for extracting point mutation mentions from text , 2007, Bioinform..

[19]  Nicholas C. Ide,et al.  Issues in the registration of clinical trials. , 2007, JAMA.

[20]  Dina Demner-Fushman,et al.  Application of Information Technology: Essie: A Concept-based Search Engine for Structured Biomedical Text , 2007, J. Am. Medical Informatics Assoc..

[21]  Marcelo Fiszman,et al.  Extracting Semantic Predications from Medline Citations for Pharmacogenomics , 2006, Pacific Symposium on Biocomputing.

[22]  Russ B. Altman,et al.  Extracting Subject Demographic Information From Abstracts of Randomized Clinical Trial Reports , 2007, MedInfo.

[23]  Christopher D. Manning,et al.  Generating Typed Dependency Parses from Phrase Structure Parses , 2006, LREC.

[24]  P. Bork,et al.  Literature mining for the biologist: from information retrieval to biological discovery , 2006, Nature Reviews Genetics.

[25]  Vandeghinste,et al.  LREC 2006 Proceedings. 5th Edition of the International Conference on Language Resources and Evaluation , 2006 .

[26]  Yang Huang,et al.  Combining text classification and Hidden Markov Modeling techniques for categorizing sentences in randomized clinical trial abstracts. , 2006, AMIA ... Annual Symposium proceedings. AMIA Symposium.

[27]  Yang Huang,et al.  Combining Text Classification and Hidden Markov Modeling Techniques for Structuring Randomized Clinical Trial Abstracts , 2006, AMIA.

[28]  Joyce A. Mitchell,et al.  Using literature-based discovery to identify disease candidate genes , 2005, Int. J. Medical Informatics.

[29]  D. McHale,et al.  Pharmacogenomics and the drug discovery pipeline: when should it be implemented? , 2005, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.

[30]  A. Tsien,et al.  Food and Drug Administration Modernization Act , 2004 .

[31]  Drummond Rennie,et al.  Trial registration: a great idea switches from ignored to irresistible. , 2004, JAMA.

[32]  A. Hrõbjartsson,et al.  Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. , 2004, JAMA.

[33]  Russ B. Altman,et al.  GAPSCORE: finding gene and protein names one word at a time , 2004, Bioinform..

[34]  Padmini Srinivasan,et al.  Mining MEDLINE for implicit links between dietary substances and diseases , 2004, ISMB/ECCB.

[35]  Russ B Altman,et al.  Indexing pharmacogenetic knowledge on the World Wide Web. , 2003, Pharmacogenetics.

[36]  M. Krajinovic,et al.  Polymorphism of the thymidylate synthase gene and outcome of acute lymphoblastic leukaemia , 2002, The Lancet.

[37]  Joshua M. Stuart,et al.  Integrating genotype and phenotype information: an overview of the PharmGKB project , 2001, The Pharmacogenomics Journal.

[38]  Elizabeth M. Smigielski,et al.  dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..

[39]  M. Relling,et al.  Pharmacogenomics: translating functional genomics into rational therapeutics. , 1999, Science.

[40]  D. Lindberg,et al.  Unified Medical Language System , 2020, Definitions.